Company Encyclopedia
View More
name
Assura PLC
AGR.UK
News
View More

REG - Primary Health Props Assura PLC - Acquisition of Assura plc – CMA Phase 1 Clearance

Primary Health Properties PLC (PHP) has received Phase 1 clearance from the UK's Competition and Markets Authority (CMA) for its acquisition of Assura plc, indicating no competition concerns. This allows PHP to focus on integrating the two businesses and achieving expected cost synergies of at least £9 million. CEO Mark Davies expressed optimism about the strategic benefits of the merger, which aims to enhance healthcare infrastructure and support the NHS's 10-year plan.

London Stock Exchange·
UK
AGR
0.00%
London Stock Exchange·
UK
AGR
0.00%

REG - Primary Health Props Assura PLC - Completion of Squeeze-out Procedure

Primary Health Properties PLC has completed the compulsory acquisition of Assura PLC shares as part of their recommended takeover. Following the announcement on June 23, 2025, PHP has acquired the remaining Assura shares not accepted by the final closing date of October 13, 2025. PHP has applied for the admission of 24,950,071 new shares to the FCA and London Stock Exchange, effective from October 16, 2025. Shareholders had the option to elect for more shares or cash, with results confirming the allocations. Further announcements are expected regarding the admission process.

London Stock Exchange·
UK
AGR
0.00%
London Stock Exchange·
UK
AGR
0.00%

REG - Assura plc Primary Health Props - Cancellation of LSE Listing

Assura plc has announced the cancellation of its listing on the London Stock Exchange (LSE), effective from 8:00 a.m. on October 6, 2025. This follows a joint announcement with Primary Health Properties PLC regarding an acquisition offer. Trading of Assura shares on the Johannesburg Stock Exchange (JSE) was suspended on October 3, 2025, with a delisting expected on October 23, 2025. Assura plans to re-register as a private limited company post-delisting.

London Stock Exchange·
UK
AGR
0.00%
London Stock Exchange·
UK
AGR
0.00%

Shore Capital Reaffirms Their Hold Rating on Assura plc (AGR)

Assura plc has an analyst consensus of Moderate Buy, with a price target consensus of p56.00.

Tip Ranks·
UK
AGR
0.00%
Tip Ranks·
UK
AGR
0.00%

REG - Assura plc - Result of AGM

Assura plc held its annual general meeting (AGM) on September 30, 2025, where all resolutions except for resolutions 13 to 16 were passed. Key resolutions included the approval of the Directors' Remuneration Policy and Report, re-appointment of Ernst & Young LLP as auditor, and re-election of several directors. Resolutions 17 and 18, concerning the re-registration of the Company and calling general meetings, were also passed. Assura is a leading healthcare REIT in the UK, with a portfolio valued at £3.1 billion as of March 31, 2025.

London Stock Exchange·
UK
AGR
0.00%
London Stock Exchange·
UK
AGR
0.00%